Published abstracts

2020

Vogler S, Haasis MA, van den Ham R, Suleman F.: Assessment of cross-country collaborations to improve access to medicines in the WHO European Region. In: Abstracts from the EUHEA Conference 2020. Virtual Conference, 09 July 2020.

Vogler S, Zimmermann N, Haasis MA.: Comparison of co-payment regulations for medicines in 46 countries. In: Abstracts from the EUHEA Conference 2020. Virtual Conference, 09 July 2020.

Schneider P, Rainer L, Zuba M, Vogler S.: An analysis of price developments of biological medicines after patent expiration. In: Abstracts from the EUHEA Conference 2020. Virtual Conference, 09 July 2020.

Fischer S, Vogler S.: Drug shortages: The situation in four European countries and their approaches to handle the problem. In: Abstracts from the EUHEA Conference 2020. Virtual Conference, 09 July 2020. 

2019

Vogler S, Zimmermann N, Haasis MA, Babar-Ud-Din Z, Busse R, Espin Balbino J, et al.: Can pharmaceutical pricing and reimbursement policies make a difference in promoting equitable access to affordable medicines? From diagnosis to sustainable impact. Editorial. 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies: Vienna, Austria. 23-24 October 2019. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

Pertile P, Gamba S, Vogler S.: Impact of managed-entry agreements on medicines list prices. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

Vogler S, Schneider P.: Impact of the external price referencing methodology (EPR) on medicine prices – Simulation of existing EPR models. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

van den Ham R, Vogler S, Haasis MA, Suleman F.: Together working to improve access to medicines: analysis of cross-country collaborations in Europe. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

Zimmermann N, Vogler S, Gombocz M.: Pharmaceutical pricing and reimbursement policies – Comparative analysis in 47 PPRI member countries. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

Benslaoui B, Zerhouni MW, Chikhaoui A, Fouila FZB, Habimana K, Hachri H, Bigdeli M, Vogler S, Taoufik J, Nehmi H.: Regulating medicine prices in Morocco - Effects of the medicine price decree 2014 on medicine prices. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

Habl C, Németh G, Schneider P.: How the Euripid Collaboration contributes to the affordability of medicines in Europe. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

Schneider P, Lepuschütz L, Zimmermann N, Vogler S.: Estimating price developments of biological medicines during market exclusivity. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

Schneider P, Vogler S.: Choosing the right medicines for price comparisons - Analysis of prices of pharmaceutical presentations of the same active ingredient. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

Schneider P, Habl C, Németh G.: Ex-post analysis of medicines subject to Managed-Entry-Agreements (MEAs) – a feasible approach for monitoring and price analyses. In: Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge – The value of pricing and reimbursement policies. Journal of Pharmaceutical Policy and Practice 12, 34, 2019

2016

Vogler S, Schneider P, Zimmermann N.: European price comparison of high cost hospital medicines. In: European Journal of Hospital Pharmacy, 23: A163-A164, 2016

Zimmermann N, Gombocz M, Vogler S.: How do Cost-Containment Measures Impact Pharmaceutical Industry?. In: Value in Health, 19: A347– A766, 2016

Vogler S, Schneider P, Gombocz M, Zimmermann N.: Differences In Pricing Policies For Generic And Biosimilar Medicines. In: Value in Health, 19: A347– A766, 2016

Schneider P, Lepuschütz L, Vogler S, Zimmermann N.: Impact Of Changes In The Methodology Of External Price Referencing On Prices. In: Value in Health, 19: A347– A766, 2016

Mayer S, Vogler S, Simon J, Österle A.: Exploring Determinants Of Polypharmacy In The Elderly Population in Austria. In: Value in Health, 19: A347– A766, 2016

DeRooj RH, Frederix GW, Hövels AM, Vogler S.: Relevance And Economic Consequences Of Medicine Waste In Vienna: Analysis Of A Household Garbage Sample. In: Value in Health, 19: A347– A766, 2016

Habl C, Leopold C.: What happens to originator medicines when (generic) followers enter the public market?. In: Value in Health, 19: A347– A766, 2016

Vogler S, Schneider P, Lepuschütz L, Zimmermann N.: How do policy-makers deal with missing price information when they apply External Price Referencing? . In: European Journal of Public Health, 26 (suppl_1): ckw167.069, 2016

Vogler S, Gombocz M, Zimmermann N.: Impacts of tendering for off-patent medicines on access and costs. In: European Journal of Public Health, 26 (suppl_1): ckw167.074, 2016

Vogler S, Österle A, Mayer S.: Changes in socioeconomic determinants of prescribed and non-prescribed medicines use in Austria. In: European Journal of Public Health, 26 (suppl_1): ckw174.163, 2016

2015

Vogler S et al.: Abstracts from the 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. In: Journal of Pharmaceutical Policy and Practice, Volume 8: Supplement 1, 2015

2013

Vogler S, Zimmermann N, Habl C, Leopold C, Dolinar E. OHP-073: Survey of Interface Management Measures Regarding Medicines. In: European Journal of Hospital Pharmacy: Science and Practice, 2013;20(Suppl 1): A161-A, 2013

Vogler S, Zimmermann N, Habl C, Leopold C, Habimana K, Mantel-Teeuwisse A, et al. OHP-084: What Concepts Are Used to Describe the Cooperation Mechanisms Between the Hospital Sector and Primary Care? Analysis of Terminology. In: European Journal of Hospital Pharmacy: Science and Practice , 2013;20(Suppl 1): A165-A, 2013

2011

Vogler S, Zimmermann N, Leopold C, Habl C, Mazag J.: Are Hospital Medicines Prices Influenced by Discounts and Rebates? (PHP22). In: Value in Health, 2011;14(7): A233-A510, 2011